Entheon Biomedical (XCNQ:ENBI) Other Current Receivables : C$0.01 Mil (As of Nov. 2023)

View and export this data going back to 2018. Start your Free Trial

What is Entheon Biomedical Other Current Receivables?

Entheon Biomedical's Other Current Receivables for the quarter that ended in Nov. 2023 was C$0.01 Mil.

Entheon Biomedical's quarterly Other Current Receivables increased from May. 2023 (C$0.01 Mil) to Aug. 2023 (C$0.01 Mil) but then stayed the same from Aug. 2023 (C$0.01 Mil) to Nov. 2023 (C$0.01 Mil).

Entheon Biomedical's annual Other Current Receivables increased from Nov. 2021 (C$0.03 Mil) to Nov. 2022 (C$0.04 Mil) but then declined from Nov. 2022 (C$0.04 Mil) to Nov. 2023 (C$0.01 Mil).

Entheon Biomedical Other Current Receivables Historical Data

The historical data trend for Entheon Biomedical's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Entheon Biomedical Other Current Receivables Chart

Entheon Biomedical Annual Data

Trend

Mar17

Mar18

Mar19

Mar20

Nov21

Nov22

Nov23

Other Current Receivables

Get a 7-Day Free Trial

0.12

0.01

0.03

0.04

0.01

Entheon Biomedical Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23
Other Current Receivables	Get a 7-Day Free Trial															0.04	0.08	0.01	0.01	0.01

Entheon Biomedical Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.

Entheon Biomedical Other Current Receivables Related Terms

Thank you for viewing the detailed overview of Entheon Biomedical's Other Current Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Entheon Biomedical (XCNQ:ENBI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Entheon Biomedical Corp (XCNQ:ENBI) » Definitions » Other Current Receivables

Comparable Companies

Traded in Other Exchanges

ENTBF:USA 1XU1:Germany

Address

999 West Broadway Street, Suite 720, Vancouver, BC, CAN, V5Z 1K5

Website

https://www.entheonbiomedical.com

Entheon Biomedical Corp is a biotechnology research and development company committed to developing and commercializing a portfolio of safe and effective Dimethyltryptamine based psychedelic therapeutic products (DMT Products) for the purposes of treating addiction and substance use disorders. Entheon intends to generate revenue through the sale of its DMT Products to physicians, clinics, and licensed psychiatrists in the United States, certain countries in the European Union, and throughout Canada.

Entheon Biomedical (XCNQ:ENBI) Headlines

No Headlines